Kaufmann SH - Search Results

1

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.

Knorr KL, Finn LE, Smith BD, Hess AD, Foran JM, Karp JE, Kaufmann SH. Knorr KL, et al. Among authors: kaufmann sh. Stem Cells Transl Med. 2017 Mar;6(3):840-850. doi: 10.5966/sctm.2016-0034. Epub 2016 Nov 7. Stem Cells Transl Med. 2017. PMID: 28297583 Free PMC article.

2

Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Kaufmann SH, et al. Cancer Res. 1991 Jul 1;51(13):3534-43. Cancer Res. 1991. PMID: 1647269

3

Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.

Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH. Schneider E, et al. Among authors: kaufmann sh. Blood. 1995 Jan 1;85(1):186-93. Blood. 1995. PMID: 7528566 Free article.

4

Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.

Kaufmann SH, Charron M, Burke PJ, Karp JE. Kaufmann SH, et al. Cancer Res. 1995 Mar 15;55(6):1255-60. Cancer Res. 1995. PMID: 7882318

5

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

6

Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study.

Kaufmann SH, Karp JE, Burke PJ, Gore SD. Kaufmann SH, et al. Leuk Lymphoma. 1996 Sep;23(1-2):71-83. doi: 10.3109/10428199609054804. Leuk Lymphoma. 1996. PMID: 9021688 Clinical Trial.

7

Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.

Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD, Reed JC. Kaufmann SH, et al. Blood. 1998 Feb 1;91(3):991-1000. Blood. 1998. PMID: 9446661 Free article.

8

Topoisomerase II and the response to antileukemic therapy.

Kaufmann SH, Gore SD, Miller CB, Jones RJ, Zwelling LA, Schneider E, Burke PJ, Karp JE. Kaufmann SH, et al. Leuk Lymphoma. 1998 Apr;29(3-4):217-37. doi: 10.3109/10428199809068560. Leuk Lymphoma. 1998. PMID: 9684921 Review.

9

Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.

Svingen PA, Karp JE, Krajewski S, Mesner PW Jr, Gore SD, Burke PJ, Reed JC, Lazebnik YA, Kaufmann SH. Svingen PA, et al. Among authors: kaufmann sh. Blood. 2000 Dec 1;96(12):3922-31. Blood. 2000. PMID: 11090079 Free article.

10

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J. Karp JE, et al. Among authors: kaufmann sh. Blood. 2001 Jun 1;97(11):3361-9. doi: 10.1182/blood.v97.11.3361. Blood. 2001. PMID: 11369625 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,196 results

Search Page